EUVIMEDEUVIMED entdecken
Crossref

Assessing the role of Berberine as an inhibitor of advanced glycation end products (AGEs) formation using in vitro and molecular interaction studies

Yusra Ahmad, Faisal Nabi, Sana Siddiqui, Rizwan Hasan Khan, Safia Habib, Shagufta Moin

Archives of Biochemistry and Biophysics · 2025

DOI: 10.1016/j.abb.2025.110292 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2025. Verfasst von Yusra Ahmad und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, J.N.M.C., Faculty of Medicine, Aligarh Muslim University, Aligarh, 202002, U.P., India. Hauptthemen laut MEDLINE: Berberine, Glycation End Products, Advanced, Serum Albumin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycation leads to the formation of protein aggregates and advanced glycation end products (AGEs) by non-enzymatic reaction. AGEs have been linked to several pathological conditions such as diabetes, cardiovascular disorders, Alzheimer's etc. Our research objective is understanding how methylglyoxal triggers AGEs and protein aggregate formation in human serum albumin (HSA) and how the phytochemical berberine protects it. Employing various biochemical and biophysical techniques, we explored how berberine alters human serum albumin's biochemical properties and structure during multiple glycation stages. HSA was incubated with methylglyoxal at varying concentrations of berberine for 7-14 days at a temperature range of 35-37 degrees C. Methylglyoxal induced the formation of AGEs, fibrillar aggregates and hydrophobic protein patches in HSA as demonstrated by AGEs fluorescence, Thioflavin T (ThT) fluorescence and 1-anilinonaphthalene-8-sulphonic acid (ANS) fluorescence studies. The secondary structure of HSA was also disrupted as demonstrated by CD spectroscopy. All the parameters were nearly reverted back to native HSA formed in the glycated HSA + berberine samples. Molecular docking was utilized to identify the essential HSA residues involved in the HSA-berberine complex interaction and to ascertain the spontaneous binding of berberine to the HSA subdomain, hence favouring thermodynamic binding. The binding energy of HSA-berberine was determined to be -9.1 kcal/mol. The binding of berberine to lysine and arginine residues might be linked to its anti-glycation potential, as these amino acids play an important role in the glycation of proteins. However, further research is required to validate this assertion. Therefore, our study identifies AGEs and aggregates of the clinically significant protein HSA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BerberineGlycation End Products, AdvancedSerum AlbuminHumansMolecular Docking SimulationPyruvaldehydeSpectrometry, FluorescenceProtein Structure, SecondaryGlycosylationProtein BindingProtein AggregatesSerum Albumin, Human

Stichwörter der Autor:innen

AGEsBerberineHSAMicroscopySpectroscopy

Substanzen

BerberineGlycation End Products, AdvancedPyruvaldehydeSerum AlbuminProtein AggregatesSerum Albumin, Human

Autor:innen und Institutionen

  • Department of Biochemistry, J.N.M.C., Faculty of Medicine, Aligarh Muslim University, Aligarh, 202002, U.P., India.
  • Interdisciplinary Biotechnology Unit, Faculty of Life Science, Aligarh Muslim University, Aligarh, 202002, U.P., India.
  • Department of Biochemistry, J.N.M.C., Faculty of Medicine, Aligarh Muslim University, Aligarh, 202002, U.P., India. Electronic address: moinshagufta2@gmail.com.

Zitieren

APA

Ahmad, Y., Nabi, F., Siddiqui, S., Khan, R. H., Habib, S., & Moin, S. (2025). Assessing the role of Berberine as an inhibitor of advanced glycation end products (AGEs) formation using in vitro and molecular interaction studies. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2025.110292

Vancouver

Ahmad Y, Nabi F, Siddiqui S, Khan RH, Habib S, Moin S. Assessing the role of Berberine as an inhibitor of advanced glycation end products (AGEs) formation using in vitro and molecular interaction studies. Archives of Biochemistry and Biophysics. 2025. doi:10.1016/j.abb.2025.110292

BibTeX
@article{Ahmad2025,
  author = {Ahmad, Yusra and Nabi, Faisal and Siddiqui, Sana and Khan, Rizwan Hasan and Habib, Safia and Moin, Shagufta},
  title = {Assessing the role of Berberine as an inhibitor of advanced glycation end products (AGEs) formation using in vitro and molecular interaction studies},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2025},
  doi = {10.1016/j.abb.2025.110292}
}
Kostenlos starten →